ATE413174T1 - Nicht-nucleoside revers-transcriptase inhibitoren - Google Patents
Nicht-nucleoside revers-transcriptase inhibitorenInfo
- Publication number
- ATE413174T1 ATE413174T1 AT03793809T AT03793809T ATE413174T1 AT E413174 T1 ATE413174 T1 AT E413174T1 AT 03793809 T AT03793809 T AT 03793809T AT 03793809 T AT03793809 T AT 03793809T AT E413174 T1 ATE413174 T1 AT E413174T1
- Authority
- AT
- Austria
- Prior art keywords
- independently
- alkyl
- reverse transcriptase
- transcriptase inhibitors
- nucleoside reverse
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02019997 | 2002-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE413174T1 true ATE413174T1 (de) | 2008-11-15 |
Family
ID=31970278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03793809T ATE413174T1 (de) | 2002-09-05 | 2003-09-05 | Nicht-nucleoside revers-transcriptase inhibitoren |
Country Status (12)
Country | Link |
---|---|
US (1) | US7517992B2 (de) |
EP (1) | EP1534276B1 (de) |
JP (1) | JP2005538155A (de) |
KR (1) | KR20050033663A (de) |
CN (1) | CN1694700A (de) |
AT (1) | ATE413174T1 (de) |
AU (1) | AU2003260492B2 (de) |
CA (1) | CA2501924A1 (de) |
DE (1) | DE60324568D1 (de) |
MX (1) | MXPA05002545A (de) |
WO (1) | WO2004021969A2 (de) |
ZA (1) | ZA200501805B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2550187C (en) * | 2004-01-08 | 2012-08-07 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
US7442808B2 (en) | 2006-05-15 | 2008-10-28 | Merck & Co., Inc. | Antidiabetic bicyclic compounds |
WO2009058237A1 (en) * | 2007-10-29 | 2009-05-07 | Merck & Co., Inc. | Antidiabetic tricyclic compounds |
WO2014206344A1 (en) * | 2013-06-28 | 2014-12-31 | Beigene, Ltd. | Fused tricyclic amide compounds as multiple kinase inhibitors |
KR102272606B1 (ko) | 2013-06-28 | 2021-07-05 | 베이진 엘티디 | Raf 키나아제 및/또는 raf 키나아제 이량체 저해제로서 융합 트리시클릭 우레아 화합물 |
GB201522179D0 (en) * | 2015-12-16 | 2016-01-27 | Autifony Therapeutics Ltd | Novel compounds |
CN110551063A (zh) * | 2019-10-17 | 2019-12-10 | 山东邹平大展新材料有限公司 | 一种合成5-(n-boc-哌嗪-1-基)吡啶-2-胺的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999051613A1 (en) | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
SE0100733D0 (sv) * | 2001-03-05 | 2001-03-05 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
SE0102867D0 (sv) * | 2001-08-28 | 2001-08-28 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
CA2550187C (en) * | 2004-01-08 | 2012-08-07 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
-
2003
- 2003-09-05 JP JP2004533489A patent/JP2005538155A/ja not_active Withdrawn
- 2003-09-05 AT AT03793809T patent/ATE413174T1/de not_active IP Right Cessation
- 2003-09-05 WO PCT/EP2003/009872 patent/WO2004021969A2/en active IP Right Grant
- 2003-09-05 US US10/526,598 patent/US7517992B2/en not_active Expired - Fee Related
- 2003-09-05 CA CA002501924A patent/CA2501924A1/en not_active Abandoned
- 2003-09-05 DE DE60324568T patent/DE60324568D1/de not_active Expired - Fee Related
- 2003-09-05 AU AU2003260492A patent/AU2003260492B2/en not_active Ceased
- 2003-09-05 KR KR1020057003854A patent/KR20050033663A/ko not_active Application Discontinuation
- 2003-09-05 MX MXPA05002545A patent/MXPA05002545A/es not_active Application Discontinuation
- 2003-09-05 CN CNA038249332A patent/CN1694700A/zh active Pending
- 2003-09-05 EP EP03793809A patent/EP1534276B1/de not_active Expired - Lifetime
-
2005
- 2005-03-02 ZA ZA200501805A patent/ZA200501805B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US7517992B2 (en) | 2009-04-14 |
DE60324568D1 (en) | 2008-12-18 |
WO2004021969A3 (en) | 2004-08-05 |
ZA200501805B (en) | 2005-09-08 |
EP1534276A2 (de) | 2005-06-01 |
KR20050033663A (ko) | 2005-04-12 |
EP1534276B1 (de) | 2008-11-05 |
AU2003260492B2 (en) | 2007-03-01 |
MXPA05002545A (es) | 2005-09-30 |
AU2003260492A1 (en) | 2004-03-29 |
JP2005538155A (ja) | 2005-12-15 |
CA2501924A1 (en) | 2004-03-18 |
CN1694700A (zh) | 2005-11-09 |
WO2004021969A2 (en) | 2004-03-18 |
US20060167055A1 (en) | 2006-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300877I2 (nl) | obeticholzuur | |
EA200602060A1 (ru) | Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы | |
RS52632B (en) | S-TRIAZOLYL ALFA-MERCAPTOACETANILIDE AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE | |
ATE362360T1 (de) | Hemmer des phosphattransports | |
NZ511739A (en) | New esters derived from substituted phenyl-cyclohexyl compounds | |
NO20062644L (no) | DPP-IV inhibitorer | |
ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
HUP0302367A2 (hu) | HIV Integráz inhibitorokként hasznos aza- és poliazanaftalenil-karboxamidok, ezeket tartalmazó gyógyszerkészítmények | |
RS91404A (en) | Derivatives of n-(phenyl(piperidin-2- yl)benzamide, the preparation method thereof and application of same in therapeutics | |
RS20050182A (en) | Derivatives of dioxane-2-alkyl carbamates,preparation method thereof and application of same in therapeutics | |
ATE374773T1 (de) | Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten | |
TW200612920A (en) | Novel imidazolidine derivatives | |
UA85502C2 (en) | Diazaindole-dicarbonyl-piperazinyl antiviral agents | |
NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
UA88329C2 (en) | Dna-pk inhibitors | |
DE60330758D1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
ATE413174T1 (de) | Nicht-nucleoside revers-transcriptase inhibitoren | |
TW200505446A (en) | Inhibitor of cox | |
ATE308540T1 (de) | Antithrombosemittel | |
MXPA04009421A (es) | Compuestos de tiazol-2-ilimina como inhibidores de la pde-7. | |
MXPA05009607A (es) | Derivados de n-fenil-[(4-piridil)-azinil]-amina como agentes protectores de plantas. | |
ATE348800T1 (de) | 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren | |
BR0207886A (pt) | Ciclopropa-heterociclos como inibidores de transcriptase reversa não-nucleosìdeos | |
WO2004099130A3 (en) | 1,2-diarylimidazoles useful as inhibitors of cox | |
TR200100070A2 (tr) | Bileşim |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |